Clinical Trial Update: Adjunctive Cilostazol Versus High Maintenance-dose ClopidogrEL in Acute Myocardial Infarction (AMI) Patients According to CYP2C19 Polymorphism [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing adjunctive cilostazol versus high maintenance-dose clopidogrel in acute myocardial infarction patients, examining outcomes by CYP2C19 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED